By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IBM will collaborate with researchers at the University of Melbourne in Australia to provide life sciences researchers in the area with access to high-performance computing, including IBM's Blue Gene, to conduct a range of human disease studies.

The collaboration will involve IBM's Research Computational Biology Center, the Victorian Life Sciences Computational Initiative (VLSCI), and as many as 10,000 other researchers spread around the Melbourne area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease. 

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.